Correlation Between Fortress Biotech and Rigel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Fortress Biotech and Rigel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fortress Biotech and Rigel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fortress Biotech and Rigel Pharmaceuticals, you can compare the effects of market volatilities on Fortress Biotech and Rigel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fortress Biotech with a short position of Rigel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fortress Biotech and Rigel Pharmaceuticals.
Diversification Opportunities for Fortress Biotech and Rigel Pharmaceuticals
-0.45 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Fortress and Rigel is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Fortress Biotech and Rigel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rigel Pharmaceuticals and Fortress Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fortress Biotech are associated (or correlated) with Rigel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rigel Pharmaceuticals has no effect on the direction of Fortress Biotech i.e., Fortress Biotech and Rigel Pharmaceuticals go up and down completely randomly.
Pair Corralation between Fortress Biotech and Rigel Pharmaceuticals
Given the investment horizon of 90 days Fortress Biotech is expected to under-perform the Rigel Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Fortress Biotech is 2.26 times less risky than Rigel Pharmaceuticals. The stock trades about -0.07 of its potential returns per unit of risk. The Rigel Pharmaceuticals is currently generating about 0.32 of returns per unit of risk over similar time horizon. If you would invest 1,452 in Rigel Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of 1,218 from holding Rigel Pharmaceuticals or generate 83.88% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Fortress Biotech vs. Rigel Pharmaceuticals
Performance |
| Timeline |
| Fortress Biotech |
| Rigel Pharmaceuticals |
Fortress Biotech and Rigel Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Fortress Biotech and Rigel Pharmaceuticals
The main advantage of trading using opposite Fortress Biotech and Rigel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fortress Biotech position performs unexpectedly, Rigel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rigel Pharmaceuticals will offset losses from the drop in Rigel Pharmaceuticals' long position.| Fortress Biotech vs. Mustang Bio | Fortress Biotech vs. Achilles Therapeutics PLC | Fortress Biotech vs. Aptose Biosciences | Fortress Biotech vs. Fortress Biotech Pref |
| Rigel Pharmaceuticals vs. Fortress Biotech | Rigel Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Rigel Pharmaceuticals vs. Pieris Pharmaceuticals | Rigel Pharmaceuticals vs. Cidara Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |